Citizens JMP Maintains Neutral Stance on Intellia Despite Positive Lonvo-z Data
Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the best CRISPR stocks to buy. Citizens JMP reaffirmed its Market Perform rating on Intellia Therapeutics, Inc.
Posts Tagged ‘NASDAQ:NTLA’
Top 10 CRISPR Stocks to Buy Now
Innovation is a hallmark of the biopharmaceutical sector, which is fueled by the demand for novel therapies to address unresolved medical needs.
Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
Intellia Therapeutics, Inc. (NTLA) Backed by H.C. Wainwright for 237% Upside Potential
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the best NASDAQ stocks under $50 to buy. Analysts at H.C.
10 Best NASDAQ Stocks Under $50 to Buy
In this era where everyone is striving for the best, whether it be something in daily life or technology, the stock market is no exception.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Intellia' First Quarter 2025 Financial Results Conference Call. My name is Drew, and I will be your conference operator today.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2024 Earnings Call Transcript
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2024 Earnings Call Transcript February 27, 2025Intellia Therapeutics, Inc. beats earnings expectations.
Cathie Wood’s Stock Portfolio: 2025 Stock Picks
Cathie Wood is one of Wall Street's most contentious figures.
Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like...
10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2024 Earnings Call Transcript
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2024 Earnings Call Transcript November 7, 2024Intellia Therapeutics, Inc. beats earnings expectations.
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics...
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
10 Stocks That Will Change the World
If we were to try and summarize one of the biggest ways how to make money on the stock market, it'd include buying stocks of firms that have changed the world.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2024 Earnings Call Transcript
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2024 Earnings Call Transcript August 8, 2024Intellia Therapeutics, Inc. misses on earnings expectations.
Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) the Most Promising Gene Therapy Stock to Buy Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Intellia Therapeutics, Inc.
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
15 Best ARK Stocks To Buy Now
Cathie Wood is one of the most polarizing, and prominent figures on Wall Street.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Intellia Therapeutics’ First Quarter 2024 Financial Results Conference Call.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript
Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc.
Top 11 CRISPR Stocks To Invest In
In this article, we discuss the top 11 CRISPR stocks to invest in.
13 Most Promising Future Stocks To Buy According To Hedge Funds
In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds.
5 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.
5 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the five best genomics stocks to buy now.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood’s Portfolio
In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.
5 Biotech Stocks with Biggest Upside
In this article, we discuss 5 biotech stocks with biggest upside.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Intellia Therapeutics' Second Quarter 2023 Earnings Conference Call. My name is Drew and I will be your conference operator today.
10 DNA Stocks Billionaires Are Loading Up On
In this article, we discuss 10 DNA stocks that billionaires love.
13 Best Future Stocks for the Long-Term
Investing these days is a ride not for the faint hearted.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Intellia Therapeutics' First Quarter 2023 Financial Results Conference Call.
5 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
5 Best Mid-Cap Healthcare Stocks To Buy Now
In this article, we discuss 5 best mid-cap healthcare stocks to buy now.
Top 5 CRISPR Stocks To Buy
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
5 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
12 Cheap Healthcare Stocks to Buy in 2023
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the Intellia Therapeutics' Fourth Quarter and Full Year 2022 Financial Results Conference Call.
5 Most Promising Biotech Stocks According to Analysts
In this article, we discuss 5 most promising biotech stocks according to analysts.
Ark Invest Stock Portfolio: 15 Biggest Positions
In this article, we discuss the 15 biggest positions in the ARK Invest portfolio.
Cathie Wood Is Loading Up On These 12 Stocks
If there's one thing that can be said for certain in today's highly volatile environment, it's that 2022 has not been a good year for Cathie Wood. Ms.
14 Best ARK Stocks To Buy Now
In this article, we discuss the 14 best ARK stocks to buy now.
10 Best Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 10 best biotech stocks to buy according to hedge funds.
5 Most Promising Gene Therapy Companies to Watch
In this piece, we will take a look at the five most promising gene therapy companies to watch.
5 Biggest Genomics Companies In The World
In this article, we will discuss the 5 Biggest Genomics Companies In The World.
ARK Invest Stock Portfolio: Top 10 Picks
In this article, we discuss the top 10 stock picks from the ARK Invest stock portfolio.
5 Best Gene Editing Stocks To Buy
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California.
